MMWR Weekly - December 14, 2007 / 56(49);1291-1292
In 1996, the U.S. Public Health Service first recommended using antiretrovirals as postexposure prophylaxis (PEP) after occupational exposure to human immunodeficiency virus (HIV) (1). Since the updated HIV PEP recommendations in 2005 (2), two important changes to antiretroviral use have occurred that affect the management of occupational exposures.
Symptomatic early neurosyphilis is a rare manifestation of syphilis that usually occurs within the first 12 months of infection (1). Most neurologic symptoms of early neurosyphilis result from acute or subacute meningitis, abnormalities in cranial nerve function, and inflammatory vasculitis leading to a cerebrovascular accident.